AA
ALPS Advisors’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
+69,614
| New | +$2.26M | 0.01% | 351 |
|
|
2024
Q2 | – | Sell |
-76,316
| Closed | -$5.21M | – | 991 |
|
|
2024
Q1 | $5.21M | Buy |
76,316
+11,021
| +17% | +$753K | 0.04% | 233 |
|
|
2023
Q4 | $4.1M | Sell |
65,295
-4,010
| -6% | -$252K | 0.03% | 240 |
|
|
2023
Q3 | $3.53M | Buy |
69,305
+426
| +0.6% | +$21.7K | 0.03% | 244 |
|
|
2023
Q2 | $3.44M | Buy |
68,879
+16,153
| +31% | +$807K | 0.03% | 228 |
|
|
2023
Q1 | $1.98M | Sell |
52,726
-881
| -2% | -$33K | 0.02% | 292 |
|
|
2022
Q4 | $2.57M | Buy |
53,607
+21,196
| +65% | +$1.02M | 0.02% | 255 |
|
|
2022
Q3 | $778K | Sell |
32,411
-2,184
| -6% | -$52.4K | 0.01% | 516 |
|
|
2022
Q2 | $753K | Buy |
+34,595
| New | +$753K | 0.01% | 516 |
|